panitumumab
amgen,takeda
['lymsm', 'dlbcl', 'paradigm', 'lymphoma']
excited for this evening's #asco22 lymphoma paradigm discussion chaired by dr. sehn. will tweet updates in this thread. first up: frontline dlbcl management. #lymsm 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????